Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Protective Role of (RS )-glucoraphanin Bioactivated with Myrosinase in an Experimental Model of Multiple Sclerosis.
Phenytoin in acute optic neuritis: neuroprotective or not?
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.
MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis.
The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
[Diagnosis and treatment of pelvic disorders in patients with multiple sclerosis].
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Chronic pain in episodic illness and its influence on work occupations: A scoping review.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
Facilitation of Corticospinal Connections in Able-bodied People and People With Central Nervous System Disorders Using Eight Interventions.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Myelin and macrophages in the PNS: An intimate relationship in trauma and disease.
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
288
289
290
291
292
293
294
295
296
…
next ›
last »